bioAffinity Technologies (BIAF) Shares Outstanding (Diluted Average) (2022 - 2026)

bioAffinity Technologies (BIAF) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $4.5 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $4.5 million, up 729.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (up 729.53% YoY), and the FY2025 annual result was $1.7 million, up 325.83% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $4.5 million in Q1 2026 per BIAF's latest filing, from $1.7 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $24.0 million in Q2 2025 and troughed at $374445.0 in Q3 2024.
• A 5-year average of $6.1 million and a median of $4.5 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) plunged 95.69% in 2024, then jumped 729.53% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.5 million in 2022, then surged by 94.43% to $8.7 million in 2023, then sank by 95.38% to $404167.0 in 2024, then surged by 325.83% to $1.7 million in 2025, then soared by 161.16% to $4.5 million in 2026.
• Business Quant data shows BIAF's Shares Outstanding (Diluted Average) at $4.5 million in Q1 2026, $1.7 million in Q4 2025, and $1.1 million in Q3 2025.